President Donald Trump unveiled the Great Healthcare Plan to lower drug costs and insurance premiums, but healthcare executives say the proposal lacks sufficient detail to assess whether it would meaningfully reduce costs.
Executives from Merck, GE Healthcare and Alnylam Pharmaceuticals discuss past hurdles and how it has scrambled supply chains and clinical trial program. One warned about the effects of isolating China.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
CMS has introduced the MAHA ELEVATE model to expand lifestyle medicine in Medicare, a move experts support but say will hinge on effective implementation.
The weight loss market is at yet another inflection point. The euphoria of the past three years is now confronting the realities of how obesity medications will scale to address an epidemic that impacts over 1 billion people globally.
A report supporting the CDC’s revisions says the U.S. is an outlier in the number of diseases and the total number of vaccine doses recommended in its pediatric vaccine schedule. But some physician groups say comparisons to other countries can be misguided and removing vaccines from the schedule puts children’s health at risk.
The DEA’s anticipated extension of telehealth prescribing flexibility once again averts an immediate disruption in care, but it leaves providers and patients in the same cycle of uncertainty that has persisted for years.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
The American Medical Association is urging Congress to permanently extend Medicare’s pandemic-era telehealth flexibilities, warning that temporary extensions create uncertainty for patients and providers.
There is no question the pressures are heavy, but there is also an opportunity for organizations to rethink how they deliver care, how they support the people they serve, and how they invest limited resources.
The decision to eliminate nursing and PA degrees from ‘professional degree’ status isn’t just a financial policy choice; it’s a workforce policy choice. And, unfortunately, it’s moving in the wrong direction at the worst possible time.
When tax-advantaged dollars enter a care model, they do more than expand purchasing power. They reorganize incentives, accelerate intermediary involvement, and clarify who holds leverage.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
The DEA extended telemedicine prescribing flexibilities for controlled substances through the end of 2026, drawing praise from telehealth advocates who are urging a permanent solution.
Rising healthcare costs and flaws in the Medicare Advantage program are likely to dominate healthcare reform discussions in 2026, according to one PitchBook analyst. Potential policy changes could focus on improving affordability in the ACA market and fixing distorted incentives in Medicare Advantage.
A handful of states have issued guidance documents that illustrate how regulators are viewing the IV hydration and IV therapy businesses, which infusion providers should consider as part of their overall compliance monitoring efforts.
HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and scrap planned transparency requirements for healthcare AI tools. The agency argues the move will reduce regulatory burden and save developers time and money.
We should never wait for tragedies to force a conversation around clear governance and accountability. Oversight has to evolve alongside innovation to protect people before harm occurs.